TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
KZIA

Kazia Therapeutics Ltd

Healthcare · Biotechnology

9.30$ -2.1% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Balance Sheet

Kazia Therapeutics Ltd (KZIA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q4 25), "Total Assets" came in at 71 million AUD. Tick rows to compare them in a chart.

All figures in millions of AUD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet KZIA
Line item Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q2 24 Q3 24 Q4 24 Q2 25 Q3 25 Q4 25
36 28 – 28 28 24 22 22 18 6.1 6.1 71
9.4 5.9 11 11 11 8.0 6.1 6.1 3.4 4.9 4.9 70
7.4 4.4 – 5.2 5.2 3.6 1.7 1.7 3.1 4.3 4.3 69
7.4 4.4 – 5.2 5.2 3.6 – 1.7 3.1 – 4.3 69
0.7 0.7 0.1 0.1 0.1 0.1 0.0 0.1 0.1 – 0.1 0.3
– – – – -0.1 -0.1 – – – – – –
19 18 – 17 17 16 15 15 14 1.1 1.1 1.1
18 16 – 16 16 19 32 32 22 14 14 25
6.7 5.6 7.6 7.6 7.6 11 26 26 17 14 14 24
1.8 0.6 – 1.8 1.8 0.4 – 0.6 0.1 – 0.4 0.1
1.5 2.3 0.9 0.9 0.9 1.0 4.5 4.5 6.3 5.6 5.6 6.1
18 12 – 12 12 5.3 -10 -10 -3.8 -8.3 -8.3 46
-69 -82 -89 -89 -89 -98 -115 -115 -125 -135 -135 -145
0.3 0.3 223 236 0.5 0.5 333 0.6 0.9 809 1.6 3.1

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?